Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Novo Nordisk slashes price of Ozempic

NBC New York · 1d
Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients
Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
Yahoo · 1d
US cash-paying customers can now get Ozempic for half price
Novo Nordisk announced Monday that people who use Ozempic can now get it for half the price if you pay in cash.
Fortune on MSN · 2d
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover Ozempic. More than 70,000 U.S. pharmacies are participating through partnerships with GoodRx and NovoCare, Novo Nordisk’s cash-pay pharmacy.
2don MSN

Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings, at $499 Per Month. Why GoodRx Stock Spikes.

GoodRx offers coupons for reduced prescription drug prices at retail pharmacies. The company says patients will be able to ...
ConsumerAffairs
8h

GoodRx teams up with Novo Nordisk to make weight loss drugs more affordable

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...
Explícame on MSN2d

Novo Nordisk announces significant price cut for its most coveted diabetes drug

Novo Nordisk launches a new cash-pay option for a leading diabetes drug, changing affordability dynamics for uninsured ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy